Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

1972 • 31,801 citations

Regression Models and Life-Tables

1992 • 27,454 citations

Evaluation of survival data and two new rank order statistics arising in its consideration.

1966 • 7,595 citations

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

1996 • 7,450 citations

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

1995 • 7,378 citations

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels

1998 • 5,293 citations

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1998 • 5,229 citations

PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA

1995 • 3,524 citations

High-Density Lipoprotein — The Clinical Implications of Recent Studies

1989 • 1,565 citations

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

1978 • 1,058 citations

Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study

1988 • 946 citations

Ten-Year Mortality from Cardiovascular Disease in Relation to Cholesterol Level among Men with and without Preexisting Cardiovascular Disease

1990 • 834 citations

Risk Factors for Coronary Artery Disease in Healthy Persons with Hyperinsulinemia and Normal Glucose Tolerance

1989 • 792 citations

The Minnesota code manual of electrocardiographic findings: Standards and procedures for measurement and classification

1982 • 712 citations

Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)

1998 • 639 citations

Fasting Insulin and Apolipoprotein B Levels and Low-Density Lipoprotein Particle Size as Risk Factors for Ischemic Heart Disease

1998 • 432 citations

Isolated Low HDL Cholesterol As a Risk Factor for Coronary Heart Disease Mortality

1997 • 393 citations

Relationship Between Plasma LDL Concentrations During Treatment With Pravastatin and Recurrent Coronary Events in the Cholesterol and Recurrent Events Trial

1998 • 381 citations

The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation

1993 • 304 citations

The B-Value: A Tool for Monitoring Data

1988 • 302 citations

Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.

1987 • 263 citations

Distribution of lipids in 8,500 men with coronary artery disease

1995 • 241 citations

Prevalence of Risk Factors in Men With Premature Coronary Artery Disease

1992 • 215 citations

Cost and health implications of cholesterol lowering.

1992 • 214 citations

Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study

1988 • 210 citations

Reverse Cholesterol Transport—A Review of the Process and Its Clinical Implications

1997 • 122 citations

Sample size determination in clinical trials with time-dependent rates of losses and noncompliance

1986 • 105 citations

Rationale and design of the Department of Veterans Affairs high-density lipoprotein cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol

1993 • 99 citations

The Helsinki Heart Study: an 8.5‐year safety and mortality follow‐up

1994 • 95 citations

The veterans affairs high-density lipoprotein intervention trial: Baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol

1996 • 68 citations

Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapy

1994 • 49 citations

Effects of treatment of hypertriglyceridaemia with gemfibrozil on serum lipoproteins and the transfer of cholesteryl ester from high density lipoproteins to low density lipoproteins

1992 • 47 citations

Secondary Prevention for Ischemic Heart Disease

1997 • 28 citations

Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels

1996 • 20 citations

Secondary prevention for ischemic heart disease. Relative numbers needed to treat with different therapies

1997 • 10 citations

Simultaneous Screening for Three Correlated Lipids in the VA HDL Intervention Trial

1999 • 2 citations